Multi-pathway longevity formula targeting twelve hallmarks of aging simultaneously. Seven of its twelve ingredients carry published human trial data at or near the doses included. The synergy across hallmarks is a structural strength that single-ingredient alternatives cannot replicate.
Enter your email and we'll send you the complete report.
Nitric oxide support via beetroot and hawthorn with clinical dosing within published ranges. The lozenge delivery format offers measurably higher bioavailability than capsule alternatives for the nitrate pathway. Evidence supports cardiovascular and exercise performance benefits in adults over 40.
Enter your email and we'll send you the complete report.
Targeted red light therapy device operating at clinically documented wavelengths. The portable form factor and focused beam design address a practical gap in home-use photobiomodulation that panel-style devices leave open. Published pilot data supports joint and tissue recovery applications.
Enter your email and we'll send you the complete report.
NAD+ precursor supplement combining NMN with complementary cofactors for cellular energy metabolism. The formulation addresses the well-documented age-related decline in NAD+ levels with ingredients that have individual clinical support. Dosing aligns with published intervention ranges.
Enter your email and we'll send you the complete report.